Annual D&A
$2.69 B
+$590.00 M+28.06%
31 December 2023
Summary:
Gilead Sciences annual depreciation & amortization is currently $2.69 billion, with the most recent change of +$590.00 million (+28.06%) on 31 December 2023. During the last 3 years, it has risen by +$1.21 billion (+81.96%). GILD annual D&A is now at all-time high.GILD Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$690.00 M
-$4.00 M-0.58%
30 September 2024
Summary:
Gilead Sciences quarterly depreciation & amortization is currently $690.00 million, with the most recent change of -$4.00 million (-0.58%) on 30 September 2024. Over the past year, it has increased by +$6.00 million (+0.88%). GILD quarterly D&A is now -0.58% below its all-time high of $694.00 million, reached on 30 June 2024.GILD Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.76 B
+$6.00 M+0.22%
30 September 2024
Summary:
Gilead Sciences TTM depreciation & amortization is currently $2.76 billion, with the most recent change of +$6.00 million (+0.22%) on 30 September 2024. Over the past year, it has increased by +$229.00 million (+9.04%). GILD TTM D&A is now at all-time high.GILD TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.1% | +0.9% | +9.0% |
| 3 y3 years | +82.0% | +31.9% | +42.2% |
| 5 y5 years | +88.5% | +98.8% | +95.6% |
GILD Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +82.0% | -0.6% | +31.9% | at high | +42.2% |
| 5 y | 5 years | at high | +91.8% | -0.6% | +98.8% | at high | +98.1% |
| alltime | all time | at high | >+9999.0% | -0.6% | >+9999.0% | at high | >+9999.0% |
Gilead Sciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $690.00 M(-0.6%) | $2.76 B(+0.2%) |
| June 2024 | - | $694.00 M(+0.6%) | $2.76 B(+0.5%) |
| Mar 2024 | - | $690.00 M(+0.3%) | $2.74 B(+1.9%) |
| Dec 2023 | $2.69 B(+28.1%) | $688.00 M(+0.6%) | $2.69 B(+6.3%) |
| Sept 2023 | - | $684.00 M(+0.4%) | $2.53 B(+6.7%) |
| June 2023 | - | $681.00 M(+6.4%) | $2.37 B(+7.0%) |
| Mar 2023 | - | $640.00 M(+21.2%) | $2.22 B(+5.5%) |
| Dec 2022 | $2.10 B(+2.6%) | $528.00 M(+0.6%) | $2.10 B(-0.3%) |
| Sept 2022 | - | $525.00 M(0.0%) | $2.11 B(+0.1%) |
| June 2022 | - | $525.00 M(0.0%) | $2.11 B(+0.3%) |
| Mar 2022 | - | $525.00 M(-1.9%) | $2.10 B(+2.5%) |
| Dec 2021 | $2.05 B(+38.5%) | $535.00 M(+2.3%) | $2.05 B(+5.6%) |
| Sept 2021 | - | $523.00 M(+0.8%) | $1.94 B(+9.5%) |
| June 2021 | - | $519.00 M(+9.7%) | $1.77 B(+10.6%) |
| Mar 2021 | - | $473.00 M(+10.8%) | $1.60 B(+8.4%) |
| Dec 2020 | $1.48 B(+5.4%) | $427.00 M(+20.3%) | $1.48 B(+5.5%) |
| Sept 2020 | - | $355.00 M(+1.7%) | $1.40 B(+0.6%) |
| June 2020 | - | $349.00 M(0.0%) | $1.40 B(+0.1%) |
| Mar 2020 | - | $349.00 M(-0.3%) | $1.39 B(-0.7%) |
| Dec 2019 | $1.40 B(-1.7%) | $350.00 M(+0.9%) | $1.40 B(-0.6%) |
| Sept 2019 | - | $347.00 M(-0.3%) | $1.41 B(-0.8%) |
| June 2019 | - | $348.00 M(-3.1%) | $1.42 B(-0.6%) |
| Mar 2019 | - | $359.00 M(+0.3%) | $1.43 B(+0.1%) |
| Dec 2018 | $1.43 B(+11.1%) | $358.00 M(0.0%) | $1.43 B(-2.7%) |
| Sept 2018 | - | $358.00 M(+0.6%) | $1.47 B(+4.3%) |
| June 2018 | - | $356.00 M(-0.3%) | $1.41 B(+4.3%) |
| Mar 2018 | - | $357.00 M(-10.1%) | $1.35 B(+4.9%) |
| Dec 2017 | $1.29 B(+11.1%) | $397.00 M(+33.7%) | $1.29 B(+8.9%) |
| Sept 2017 | - | $297.00 M(-0.3%) | $1.18 B(-0.2%) |
| June 2017 | - | $298.00 M(+1.4%) | $1.18 B(+1.2%) |
| Mar 2017 | - | $294.00 M(+0.7%) | $1.17 B(+0.9%) |
| Dec 2016 | $1.16 B(+5.5%) | $292.00 M(-2.3%) | $1.16 B(+1.2%) |
| Sept 2016 | - | $299.00 M(+5.3%) | $1.14 B(+1.9%) |
| June 2016 | - | $284.00 M(+0.4%) | $1.12 B(+1.0%) |
| Mar 2016 | - | $283.00 M(+1.8%) | $1.11 B(+1.3%) |
| Dec 2015 | $1.10 B(+4.6%) | $278.00 M(0.0%) | $1.10 B(+0.3%) |
| Sept 2015 | - | $278.00 M(+1.8%) | $1.09 B(+0.9%) |
| June 2015 | - | $273.00 M(+1.5%) | $1.08 B(+0.6%) |
| Mar 2015 | - | $269.00 M(-2.2%) | $1.08 B(+2.7%) |
| Dec 2014 | $1.05 B(+204.3%) | $275.00 M(+2.6%) | $1.05 B(+16.2%) |
| Sept 2014 | - | $268.00 M(+0.8%) | $903.25 M(+28.2%) |
| June 2014 | - | $266.00 M(+10.4%) | $704.50 M(+37.7%) |
| Mar 2014 | - | $241.00 M(+87.9%) | $511.67 M(+48.3%) |
| Dec 2013 | $345.00 M(+24.1%) | $128.25 M(+85.2%) | $345.00 M(+18.9%) |
| Sept 2013 | - | $69.24 M(-5.4%) | $290.17 M(-0.6%) |
| June 2013 | - | $73.18 M(-1.5%) | $291.92 M(+2.0%) |
| Mar 2013 | - | $74.33 M(+1.2%) | $286.16 M(+2.9%) |
| Dec 2012 | $278.00 M(-8.0%) | $73.42 M(+3.4%) | $278.00 M(0.0%) |
| Sept 2012 | - | $71.00 M(+5.3%) | $278.00 M(-0.7%) |
| June 2012 | - | $67.41 M(+1.9%) | $280.00 M(-2.6%) |
| Mar 2012 | - | $66.17 M(-9.9%) | $287.49 M(-4.9%) |
| Dec 2011 | $302.23 M(+13.8%) | $73.42 M(+0.6%) | $302.23 M(-1.3%) |
| Sept 2011 | - | $73.00 M(-2.5%) | $306.32 M(+1.3%) |
| June 2011 | - | $74.89 M(-7.4%) | $302.38 M(+5.6%) |
| Mar 2011 | - | $80.91 M(+4.4%) | $286.29 M(+7.8%) |
| Dec 2010 | $265.48 M(+24.7%) | $77.52 M(+12.3%) | $265.48 M(+5.3%) |
| Sept 2010 | - | $69.05 M(+17.4%) | $252.07 M(+5.0%) |
| June 2010 | - | $58.80 M(-2.2%) | $240.07 M(+2.6%) |
| Mar 2010 | - | $60.11 M(-6.2%) | $233.90 M(+9.8%) |
| Dec 2009 | $212.94 M(+36.8%) | $64.11 M(+12.4%) | $212.94 M(-6.9%) |
| Sept 2009 | - | $57.05 M(+8.4%) | $228.81 M(+26.9%) |
| June 2009 | - | $52.63 M(+34.5%) | $180.27 M(+9.2%) |
| Mar 2009 | - | $39.15 M(-51.0%) | $165.12 M(+6.1%) |
| Dec 2008 | $155.61 M | $79.97 M(+839.0%) | $155.61 M(+82.9%) |
| Sept 2008 | - | $8.52 M(-77.3%) | $85.10 M(-7.6%) |
| June 2008 | - | $37.48 M(+26.5%) | $92.12 M(+33.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $29.64 M(+213.1%) | $69.24 M(+35.0%) |
| Dec 2007 | $51.28 M(+8.4%) | $9.46 M(-39.1%) | $51.28 M(-4.3%) |
| Sept 2007 | - | $15.53 M(+6.3%) | $53.58 M(+7.7%) |
| June 2007 | - | $14.61 M(+25.2%) | $49.73 M(+4.2%) |
| Mar 2007 | - | $11.67 M(-0.8%) | $47.71 M(+0.9%) |
| Dec 2006 | $47.28 M(+32.2%) | $11.77 M(+0.7%) | $47.28 M(-0.2%) |
| Sept 2006 | - | $11.68 M(-7.2%) | $47.39 M(+0.7%) |
| June 2006 | - | $12.59 M(+12.0%) | $47.04 M(+15.1%) |
| Mar 2006 | - | $11.24 M(-5.3%) | $40.88 M(+14.3%) |
| Dec 2005 | $35.78 M(+46.6%) | $11.87 M(+4.8%) | $35.78 M(+17.9%) |
| Sept 2005 | - | $11.33 M(+76.1%) | $30.33 M(+20.8%) |
| June 2005 | - | $6.43 M(+4.9%) | $25.12 M(+1.7%) |
| Mar 2005 | - | $6.14 M(-4.5%) | $24.70 M(+1.2%) |
| Dec 2004 | $24.41 M(+17.0%) | $6.43 M(+5.1%) | $24.41 M(+1.1%) |
| Sept 2004 | - | $6.12 M(+1.8%) | $24.14 M(+4.2%) |
| June 2004 | - | $6.01 M(+2.8%) | $23.17 M(+4.8%) |
| Mar 2004 | - | $5.85 M(-5.0%) | $22.11 M(+6.0%) |
| Dec 2003 | $20.86 M(+44.6%) | $6.16 M(+19.5%) | $20.86 M(+12.2%) |
| Sept 2003 | - | $5.15 M(+4.1%) | $18.59 M(+8.2%) |
| June 2003 | - | $4.95 M(+7.7%) | $17.19 M(+9.7%) |
| Mar 2003 | - | $4.60 M(+18.3%) | $15.67 M(+8.6%) |
| Dec 2002 | $14.43 M(-1.8%) | $3.89 M(+3.8%) | $14.43 M(+0.3%) |
| Sept 2002 | - | $3.75 M(+9.2%) | $14.38 M(-0.3%) |
| June 2002 | - | $3.43 M(+2.2%) | $14.43 M(-1.2%) |
| Mar 2002 | - | $3.36 M(-12.7%) | $14.60 M(-0.6%) |
| Dec 2001 | $14.69 M(+22.3%) | $3.85 M(+1.4%) | $14.69 M(+3.7%) |
| Sept 2001 | - | $3.79 M(+5.1%) | $14.17 M(+8.3%) |
| June 2001 | - | $3.61 M(+4.7%) | $13.08 M(+4.2%) |
| Mar 2001 | - | $3.44 M(+3.7%) | $12.56 M(+4.6%) |
| Dec 2000 | $12.01 M(-4.7%) | $3.32 M(+22.5%) | $12.01 M(+1.9%) |
| Sept 2000 | - | $2.71 M(-12.1%) | $11.79 M(-5.9%) |
| June 2000 | - | $3.08 M(+6.6%) | $12.53 M(+0.2%) |
| Mar 2000 | - | $2.89 M(-6.7%) | $12.50 M(-0.8%) |
| Dec 1999 | $12.60 M(-4.5%) | $3.10 M(-10.2%) | $12.60 M(-0.8%) |
| Sept 1999 | - | $3.45 M(+13.0%) | $12.70 M(-28.8%) |
| June 1999 | - | $3.06 M(+2.1%) | $17.85 M(+15.2%) |
| Mar 1999 | - | $2.99 M(-6.5%) | $15.49 M(+17.4%) |
| Dec 1998 | $13.20 M(-13.2%) | $3.20 M(-62.8%) | $13.20 M(-42.4%) |
| Sept 1998 | - | $8.60 M(+1128.6%) | $22.90 M(+51.7%) |
| June 1998 | - | $700.00 K(0.0%) | $15.10 M(0.0%) |
| Mar 1998 | - | $700.00 K(-94.6%) | $15.10 M(-0.7%) |
| Dec 1997 | $15.20 M(+237.8%) | $12.90 M(+1512.5%) | $15.20 M(+390.3%) |
| Sept 1997 | - | $800.00 K(+14.3%) | $3.10 M(0.0%) |
| June 1997 | - | $700.00 K(-12.5%) | $3.10 M(-26.2%) |
| Mar 1997 | - | $800.00 K(0.0%) | $4.20 M(-6.7%) |
| Dec 1996 | $4.50 M(+40.6%) | $800.00 K(0.0%) | $4.50 M(+21.6%) |
| Sept 1996 | - | $800.00 K(-55.6%) | $3.70 M(-7.5%) |
| June 1996 | - | $1.80 M(+63.6%) | $4.00 M(+21.2%) |
| Mar 1996 | - | $1.10 M(0.0%) | $3.30 M(-23.3%) |
| Dec 1995 | $3.20 M(-17.9%) | - | - |
| Sept 1995 | - | $1.10 M(0.0%) | $4.30 M(+4.9%) |
| June 1995 | - | $1.10 M(0.0%) | $4.10 M(+5.1%) |
| Mar 1995 | - | $1.10 M(+10.0%) | $3.90 M(+8.3%) |
| Mar 1995 | $3.90 M(+39.3%) | - | - |
| Dec 1994 | - | $1.00 M(+11.1%) | $3.60 M(+5.9%) |
| Sept 1994 | - | $900.00 K(0.0%) | $3.40 M(+6.3%) |
| June 1994 | - | $900.00 K(+12.5%) | $3.20 M(+14.3%) |
| Mar 1994 | $2.80 M(+64.7%) | $800.00 K(0.0%) | $2.80 M(+16.7%) |
| Dec 1993 | - | $800.00 K(+14.3%) | $2.40 M(+14.3%) |
| Sept 1993 | - | $700.00 K(+40.0%) | $2.10 M(+16.7%) |
| June 1993 | - | $500.00 K(+25.0%) | $1.80 M(+5.9%) |
| Mar 1993 | $1.70 M(+70.0%) | $400.00 K(-20.0%) | $1.70 M(+30.8%) |
| Dec 1992 | - | $500.00 K(+25.0%) | $1.30 M(+62.5%) |
| Sept 1992 | - | $400.00 K(0.0%) | $800.00 K(+100.0%) |
| June 1992 | - | $400.00 K | $400.00 K |
| Mar 1992 | $1.00 M(+25.0%) | - | - |
| Mar 1991 | $800.00 K | - | - |
FAQ
- What is Gilead Sciences annual depreciation & amortization?
- What is the all time high annual D&A for Gilead Sciences?
- What is Gilead Sciences annual D&A year-on-year change?
- What is Gilead Sciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Gilead Sciences?
- What is Gilead Sciences quarterly D&A year-on-year change?
- What is Gilead Sciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Gilead Sciences?
- What is Gilead Sciences TTM D&A year-on-year change?
What is Gilead Sciences annual depreciation & amortization?
The current annual D&A of GILD is $2.69 B
What is the all time high annual D&A for Gilead Sciences?
Gilead Sciences all-time high annual depreciation & amortization is $2.69 B
What is Gilead Sciences annual D&A year-on-year change?
Over the past year, GILD annual depreciation & amortization has changed by +$590.00 M (+28.06%)
What is Gilead Sciences quarterly depreciation & amortization?
The current quarterly D&A of GILD is $690.00 M
What is the all time high quarterly D&A for Gilead Sciences?
Gilead Sciences all-time high quarterly depreciation & amortization is $694.00 M
What is Gilead Sciences quarterly D&A year-on-year change?
Over the past year, GILD quarterly depreciation & amortization has changed by +$6.00 M (+0.88%)
What is Gilead Sciences TTM depreciation & amortization?
The current TTM D&A of GILD is $2.76 B
What is the all time high TTM D&A for Gilead Sciences?
Gilead Sciences all-time high TTM depreciation & amortization is $2.76 B
What is Gilead Sciences TTM D&A year-on-year change?
Over the past year, GILD TTM depreciation & amortization has changed by +$229.00 M (+9.04%)